Spinogenix to present tazbentetol preclinical results in glaucoma and diabetic retinopathy models at ARVO 2026

Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia

Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review

Bambusa Therapeutics completes patient enrolment in Phase 1b/2a trial for atopic dermatitis

Lab Thread launches unified digital platform for biological research workflows

Curocell secures full approval for RIMQARTO to enter CAR-T therapy market

Neurocrine Biosciences reports publication of new research establishing clinically meaningful improvement threshold for TDIS

Precision Biosciences initiates patient enrollment in PBGENE-DMD clinical study

Immunome submits FDA application for varegacestat following strong Phase 3 results

HUTCHMED secures priority review for sovleplenib NDA in China

Chiesi Group to acquire KalVista Pharmaceuticals for USD1.9bn in rare disease expansion strategy

Circio partners with USC to advance non-viral RNA delivery technologies

Cirius Therapeutics introduces gestational diabetes initiative

Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence

Insilico's Rentosertib inhalation solution receives IND clearance to enter direct-to-lung clinical study